Narrow Your Search

Narrow Your Search

Focus

Publisher

Companies

People

Articles

7,916 Articles
Psychedelics Today
Psychedelics Today
/
Apr 16, 2025

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

In this episode, Joe Moore welcomes LP Giobbi, an internationally famous DJ, electronic music producer, and jazz pianist. LP shares the story behind Dead House, her project blending Grateful Dead samples with house music. What started as a tribute to her parents during pandemic live streams has...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 16, 2025

Acid? Weed? Mushrooms? MDMA? ALL AT ONCE?

Acid? Weed? Mushrooms? MDMA? ALL AT ONCE? It's common to mix shrooms and weed, MDMA and weed or acid and weed, but should you? And are there any risks? Michelle Janikian 16 Apr ` Your weekly dose of psychedelic insights and news Should You Combine Weed with Psychedelics? It's common to mix...
LSD MDMA Psychedelics
Psychedelics Today
Psychedelics Today
/
Apr 15, 2025

Psychedelic Science 2025

Psychedelic Science 2025 is the world’s largest gathering focused on psychedelic research, policy, therapy, and culture. Hosted in Denver, Colorado, this landmark event brings together leading scientists, therapists, entrepreneurs, advocates, and curious minds from around the globe. Join thousands...
Psychedelic Invest
Psychedelic Invest
/
Apr 15, 2025

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Vancouver, Canada, April 08, 2025 — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced...
Psychedelic Invest
Psychedelic Invest
/
Apr 15, 2025

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

New York, New York–(Newsfile Corp. – April 8, 2025) – Psyence BioMed (NASDAQ: PBM) (“Psyence BioMed” or the “Company”) today announced the signing of a Letter of Intent (LOI) with Southern Star Research Pty Ltd, a premier Australian contract research organization (CRO). This...
Psychedelics Today
Psychedelics Today
/
Apr 15, 2025

Kayse Gehret – The Modern Guide: Microdosing, Facilitation & Community

In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today’s Vital program. They explore what it means to be a modern guide in the world of psychedelics. Kayse shares how microdosing has become a key entry point for many and...
Psychedelics
Psychedelics Today
Psychedelics Today
/
Apr 15, 2025

Oakland Psychedelic Conference

Oakland Hosts Historic Psychedelic and Spirituality Gathering This Weekend This weekend, Oakland becomes the epicenter of psychedelic and spiritual exploration with the two-day event: Oakland Psychedelic Conference + Spirituality & Beyond 5, taking place April 19–20 at the Henry J. Kaiser...
Psychedelic Invest
Psychedelic Invest
/
Apr 15, 2025

MindBio Issues Warrants to Haywood Securities

Vancouver, British Columbia –TheNewswire -7 April, 2025–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),is a clinical stage biopharmaceutical company targeting depressive illnesses currently dosing in multiple Phase 2B clinical trials. The Company...
Psychedelic Invest
Psychedelic Invest
/
Apr 15, 2025

Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease

VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has received a notice of...
DMT
DoubleBlind Mag
DoubleBlind Mag
/
Apr 14, 2025

New Mexico Legalizes Psilocybin Therapy, But Snubs Decrim

New Mexico Legalizes Psilocybin Therapy, But Snubs Decrim PLUS, the beautiful life of Pablo Amaringo, fish on DMT, and a workshop on effective organizing for building movements psychedelically Mary Carreon // Senior Editor 14 Apr Good morning, and happy Monday! Welcome to another edition of...
Psilocybin LSD MDMA Psychedelics
Psychedelics Today
Psychedelics Today
/
Apr 14, 2025

LP Giobi – Livestream

Join us for a stream with LP Giobi, an award-winning DJ and producer with a jazz piano background. She created a set based on the work of the Grateful Dead called DEAD HOUSE. See her on April 19 at PORTAL’s Bicycle Day event or another tour date this year. Stream on our Instagram, LinkedIn or...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 11, 2025

What Chocohongos Reveal About the Return of Ritual

What Chocohongos Reveal About the Return of Ritual Before chocohongos became an underground favorite, mushrooms and cacao were partners in ceremony. Andrea Aliseda 11 Apr Deep dives and investigations you won't find anywhere else What the History of Chocohongos Says About the Return of...
Psychedelics Today
Psychedelics Today
/
Apr 11, 2025

Harry Pack – Psychedelic Surealism

Joe Moore sits down with UK-based artist Harry Pack, whose vibrant, surreal, and often psychedelic art has captured the attention of dreamers, psychonauts, and seekers worldwide. Known for channeling the aesthetic of altered states rather than simply replicating them, Harry discusses his journey...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 11, 2025

Rethinking Power, Plants, and the Future of Psychedelic Culture

Beloved members of our global psychedelic community, dear friends from Latin America, welcome to the 2025 Psychedelic Culture Conference. It is an immense honor to stand before you today as we embark on this critical gathering of minds, bodies, experiences, and visions. Over the next two days, we...
Psilocybin Alpha
Psilocybin Alpha
/
Apr 11, 2025

Pα+ Psychedelic Bulletin #193: VA Secretary on Psychedelics; Preprint Challenges Replicability of Psilocybin’s Persistent Effects in Mice; Market Mayhem and Agency Shake-Ups

As you may have heard, the new Department of Veterans Affairs VA Secretary, Doug Collins, appeared on The Shawn Ryan Show, a podcast featuring—as you may have already guessed—Shawn Ryan, “former US Navy Seal and CIA Contractor”. Some in the field are buzzing about Collins’ comments...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 09, 2025

Do Psychedelics Heal Even Without Therapy?

Do Psychedelics Heal Even Without Therapy? Some say yes, others say not so much. Dive into the debate heating up in psychedelic medicine. Mattha Busby 09 Apr Your weekly dose of psychedelic insights and news Can Psychedelics Improve Mental Health Without Therapy? As psychedelics inch...
MDMA Psychedelics
Microdose
Microdose
/
Apr 08, 2025

No More Silence: The Opioid Epidemics Alarming Impact on Women

The opioid epidemic continues to devastate communities across the country, with middle-aged women experiencing a particularly alarming rise in overdose deaths. Research from Pathways Recovery Center highlights a 260% increase in opioid-related fatalities among women aged 30-64 between 1999 and 2017....
Psilocybin Alpha
Psilocybin Alpha
/
Apr 08, 2025

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

Yesterday, New Mexico Governor Michelle Lujan Grisham (D) signed SB 219, the Medical Psilocybin Act, which will establish the third state-legal psilocybin access system in the US. In simple terms, the Act creates a framework through which patients with qualifying conditions can access and use...
Psilocybin
Psychedelics Today
Psychedelics Today
/
Apr 08, 2025

Jean-Francois Sobiecki – African Psychoactive Plants & Phytoalchemy

In this episode of Psychedelics Today, Joe Moore sits down with South African ethnobotanist and healer Jean-François Sobiecki to explore the rich and largely underrecognized world of African psychoactive plants. With over two decades of fieldwork and research, Jean-François sheds light on the...
Psychedelics
Psilocybin Alpha
Psilocybin Alpha
/
Apr 07, 2025

March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

There has been plenty of state-level psychedelic policy reform activity since our last update (see: Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States), with nearly thirty states now deliberating some sort of legislation since the year began. That includes a half-dozen news...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 07, 2025

Raving Is Having a Mental Health Renaissance

Raving Is Having a Mental Health Renaissance PLUS, dogs on MDMA, where to find underground raves near you, and camping on psychedelics Mary Carreon // Senior Editor 07 Apr Good morning, and happy Monday! Welcome to another edition of The Drop In, DoubleBlind’s newsletter delivering...
MDMA Ayahuasca
Lucid News
Lucid News
/
Apr 05, 2025

Collective Resistance and Resilience at Psychedelic Culture Conference

Part one of a two-part series.  Two presenters at the 2025 Psychedelic Culture conference in San Francisco, CA last month were denied entry into the U.S. as they attempted to cross the border from Mexico and Canada. Conference organizer Bia Labate, executive director of the Chacruna Institute for...
Psychedelics Today
Psychedelics Today
/
Apr 04, 2025

Vince Kadlubek – Meow Wolf & PORTAL

In this inspiring and far-reaching conversation, Joe Moore is joined by Vince Kadlubek, the founder and Chief Visionary Officer of Meow Wolf, the groundbreaking arts and entertainment company known for its massive, immersive art experiences. Together, they dive deep into Meow Wolf’s humble DIY...
Psychedelics Today
Psychedelics Today
/
Apr 04, 2025

The Tide Is Turning: Psychedelic Therapies Take a Step Toward the VA

A major bipartisan bill introduced on April 3rd in Congress signals a potential turning point in both psychedelic policy and the future of veterans’ healthcare. The Innovative Therapies Centers of Excellence Act of 2025, led by Representatives Lou Correa (D-CA) and Jack Bergman (R-MI), proposes...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 04, 2025

How a Rasta Village Reclaimed Psychedelics on Its Own Terms

How a Rasta Village Reclaimed Psychedelics on Its Own Terms In the hills of Montego Bay, one community is using plant medicine not for trend, but for survival, blending ritual, resistance, and a new kind of retreat. Peter Holslin 04 Apr Deep dives and investigations you won't find...
Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Mydecine Innovations Group Announces Strategic Board and Management Changes

Mydecine Innovations Group has announced significant changes to its board and management team. Peter Field, an experienced entrepreneur with a background in business development and biotech, has joined the board of directors. Additionally, Michael Callas, a tech industry leader and founder of...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

MindBio Acquires Life AI Corp. Pty. Ltd.

Vancouver, British Columbia – TheNewswire – March 26, 2025 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6), (the “Company” or “MindBio”), a clinical stage biopharmaceutical company specialising in psychedelic microdosing, is pleased to announce the completion of its...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

MindBio Adopts New Equity Incentive Plan

Vancouver, British Columbia – TheNewswire – April 2, 2025 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6), (the “Company” or “MindBio”), a clinical stage biopharmaceutical company pioneering new treatments for mental health conditions announces that it has adopted a new...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Vancouver, Canada, March 21, 2025 — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the”Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

PharmAla Contracts with Partner to Act as US Distributor

TORONTO, March 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and medical...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Filament Health Reports Q4 and Year End 2024 Financial Results and Operational Highlights

VANCOUVER, BC, April 1, 2025 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, released its fourth quarter financial results and operational highlights for the period...
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing

New York, New York–(Newsfile Corp. – March 31, 2025) – Psyence Biomedical Ltd. (NASDAQ: PBM) (“Psyence BioMed” or the “Company”) releases the following update: Dear Shareholders and Future Investors: At Psyence BioMed, we are truly grateful for the ongoing support and trust of our...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Apr 03, 2025

Neural Therapeutics Commences Trading on Frankfurt Stock Exchange

Toronto, Ontario–(Newsfile Corp. – March 31, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: M6B) (“Neural“or the “Company“), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to...
DoubleBlind Mag
DoubleBlind Mag
/
Apr 02, 2025

The Most Iconic Blotters of All Time

The Most Iconic Blotters of All Time From gold-leaf tabs to samurai sigils, these iconic blotters carry the untold stories of LSD’s most legendary designs. Michelle Lhooq 02 Apr Your weekly dose of psychedelic insights and news Eight LSD Blotters That Defined Psychedelic Culture...
LSD Ayahuasca